King Minos II hall
Hereditary nephropathies
Hereditary nephropathies
N.1A. Polycystic kidney disease
1. Safety and effectiveness of Tolvaptan Pavlos Anassis
2. New KDIGO Guidelines Vasileios Kolovos
3. Genetic tests: what should I know? Anastasios Fountoglou
N.2A. Other hereditary nephropathies
1. Fabry Disease: what should I know? Vaia Raikou
2. Type-4 collagen gene mutation related nephropathies Irini Katsipi
3. Hereditary tubulointerstitial nephropathies Ioannis Tzanakis
Anna Figueiredo (ISN / ISPD)
Anna Figueiredo (ISN / ISPD)
Vasiliki Zoi (EDTNA/ERCA)
Theodora Kafkia (EDTNA/ERCA)
N.1A. Polycystic kidney disease
1. Safety and effectiveness of Tolvaptan Pavlos Anassis
2. New KDIGO Guidelines Vasileios Kolovos
3. Genetic tests: what should I know? Anastasios Fountoglou
N.2A. Other hereditary nephropathies
1. Fabry Disease: what should I know? Vaia Raikou
2. Type-4 collagen gene mutation related nephropathies Irini Katsipi
3. Hereditary tubulointerstitial nephropathies Ioannis Tzanakis
Anna Figueiredo (ISN / ISPD)
Anna Figueiredo (ISN / ISPD)
Vasiliki Zoi (EDTNA/ERCA)
Theodora Kafkia (EDTNA/ERCA)
Dietaetics
Hereditary nephropathies
Καφές
N.3B. Renal dietetics
1. TBC
2. TBC
3. TBC
Anna Figueiredo (ISN / ISPD)
Anna Figueiredo (ISN / ISPD)
Vasiliki Zoi (EDTNA/ERCA)
Theodora Kafkia (EDTNA/ERCA)
Clinical Nephrology
Hereditary nephropathies
Καφές
N.4A. IgA nephropathy
1. The role of B cells and BAFF/APRIL Dimitrios Bakoulis
2. New and emerging therapies in IgA nephropathy Panagiotis Kompotiatis
3. How should I manage the patient with IgA nephropathy Maria Stangou
Anna Figueiredo (ISN / ISPD)
Anna Figueiredo (ISN / ISPD)
Vasiliki Zoi (EDTNA/ERCA)
Theodora Kafkia (EDTNA/ERCA)
Lunch
General assembly
Γεύμα
Haemodialysis
Hereditary nephropathies
Καφές
N.7A. Haemodialysis
1. Uremic pruritus: systematic review, evaluation and management Olga Ellina
2. Response to ultrafiltration in dialysis Nikolaos Mitsides
3. Management of the patient with diabetes on dialysis Irini Vasiliou
Anna Figueiredo (ISN / ISPD)
Anna Figueiredo (ISN / ISPD)
Vasiliki Zoi (EDTNA/ERCA)
Theodora Kafkia (EDTNA/ERCA)
Hereditary nephropathies
Hereditary nephropathies
Haemodialysis
N.2B. Quality of services and patient safety
1. Quality in practice - Diaverum paradigm
2. TBC
3. Policy on quality of services and patient safety in the Dialysis Units of the Greek National Health System
4. EN.I.N. Dialysis Unit Accreditation Program by HASIN
Anna Figueiredo (ISN / ISPD)
Anna Figueiredo (ISN / ISPD)
Vasiliki Zoi (EDTNA/ERCA)
Theodora Kafkia (EDTNA/ERCA)
Hereditary nephropathies
Breakthrough in Nephrology
Καφές
N.5A. Changing the status quo in CKD
1. SGLT2 inhibitors: what's new? Dimitrios Vlahakos
2. The place of GLP-1 agonists in clinical practice Petros Kalogeropoulos
3. The place of MRAs in clinical practice Konstantinos Psounis
Anna Figueiredo (ISN / ISPD)
Anna Figueiredo (ISN / ISPD)
Vasiliki Zoi (EDTNA/ERCA)
Theodora Kafkia (EDTNA/ERCA)
Obesity: chronic disease and axeses
State of the art lecture
Hereditary nephropathies
Hereditary nephropathies
Close
Approved by:
Participants:
Accreditation:
